The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Prevention of Antigenically Drifted Influenza by Inactivated and Live Attenuated Vaccines
Open accessAbstract
BACKGROUND: The efficacy of influenza vaccines may decline during years when the circulating viruses have antigenically drifted from those included in the vaccine. METHODS: We carried out a randomized, double-blind, placebo-controlled trial of inactivated and live attenuated influenza vaccines in healthy adults during the 2004-2005 influenza season and estimated both absolute and relative efficacies. RESULTS: A total of 1247 persons were vaccinated between October and December 2004. Influenza activity in Michigan began in January 2005 with the circulation of an antigenically drifted type A (H3N2) virus, the A/California/07/2004-like strain, and of type B viruses from two lineages. The absolute efficacy of the inactivated vaccine against both types of virus was 77% (95% confidence interval [CI], 37 to 92) as measured by isolating the virus in cell culture, 75% (95% CI, 42 to 90) as measured by either isolating the virus in cell culture or identifying it through real-time polymerase chain reaction, and 67% (95% CI, 16 to 87) as measured by either isolating the virus or observing a rise in the serum antibody titer. The absolute efficacies of the live attenuated vaccine were 57% (95% CI, -3 to 82), 48% (95% CI, -7 to 74), and 30% (95% CI, -57 to 67), respectively. The difference in efficacy between the two vaccines appeared to be related mainly to reduced protection of the live attenuated vaccine against type B viruses. CONCLUSIONS: In the 2004-2005 season, in which most circulating viruses were dissimilar to those included in the vaccine, the inactivated vaccine was efficacious in preventing laboratory-confirmed symptomatic illnesses from influenza in healthy adults. The live attenuated vaccine also prevented influenza illnesses but was less efficacious. (ClinicalTrials.gov number, NCT00133523.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2001) · PsycEXTRA Dataset · doi:10.1037/e548312006-001 · Cited by 5,011
(2002) · PsycEXTRA Dataset · doi:10.1037/e548512006-001 · Cited by 1,708
Belshe, R. B., Mendelman, P. M., Treanor, J., King, J., Gruber, W. C., Piedra, P., Bernstein, D. I., Hayden, F. G., Kotloff, K., Zangwill, K., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805143382002 · Cited by 916
Clinical signs and symptoms predicting influenza infection
Monto, A. S., Gravenstein, S., Elliott, M., Colopy, M., & Schweinle, J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.21.3243 · Cited by 752
Self-citationBridges, C. B., Thompson, W. W., Meltzer, M. I., Reeve, G. R., Talamonti, W. J., Cox, N. J., Lilac, H. A., Hall, H., Klimov, A., & Fukuda, K. (2000) · JAMA · doi:10.1001/jama.284.13.1655 · Cited by 651
WHO Manual on Animal Influenza Diagnosis and Surveillance
Manu, U. (2002) · Cited by 628
Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983
Rota, P. A., Wallis, T. R., Harmon, M. W., Rota, J. S., Kendal, A. P., & Nerome, K. (1990) · Virology · doi:10.1016/0042-6822(90)90186-u · Cited by 539
Belshe, R. B., Gruber, W. C., Mendelman, P. M., Cho, I., Reisinger, K., Block, S. L., Wittes, J., Iacuzio, D., Piedra, P., Treanor, J., et al. (2000) · The Journal of Pediatrics · doi:10.1016/s0022-3476(00)70097-7 · Cited by 431
Belshe, R. B., Gruber, W. C., Mendelman, P. M., Mehta, H. B., Mahmood, K., Reisinger, K., Treanor, J., Zangwill, K., Hayden, F. G., Bernstein, D. I., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315323 · Cited by 415
Nichol, K. L. (1999) · JAMA · doi:10.1001/jama.282.2.137 · Cited by 402
Edwards, K. M., Dupont, W. D., Westrich, M. K., Plummer, W. D., Palmer, P. S., & Wright, P. F. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/169.1.68 · Cited by 372
Treanor, J. J., Kotloff, K., Betts, R. F., Belshe, R., Newman, F., Iacuzio, D., Wittes, J., & Bryant, M. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00334-5 · Cited by 270
Weinberg, G. A., Erdman, D. D., Edwards, K. M., Hall, C. B., Walker, F. J., Griffin, M. R., Schwartz, B., & the New Vaccine Surveillance Network Study Group (2004) · The Journal of Infectious Diseases · doi:10.1086/381456 · Cited by 230
Gruber, W. C., Belshe, R. B., King, J. C., Treanor, J. J., Piedra, P. A., Wright, P. F., Reed, G. W., Anderson, E. M., & Newman, F. K. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.6.1313 · Cited by 91
King, J. C., Lagos, R., Bernstein, D. I., Piedra, P. A., Kotloff, K. L., Bryant, M. L., Cho, I., & Belshe, R. B. (1998) · The Journal of Infectious Diseases · doi:10.1086/517822 · Cited by 76
Davenport, F. M. (1973) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1973.tb111174.x · Cited by 61
Cited by
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
Osterholm, M. T., Kelley, N. S., Sommer, A., & Belongia, E. A. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70295-x · Cited by 1,789
Grohskopf, L. A., Sokolow, L. Z., Broder, K. R., Walter, E. B., Fry, A. M., & Jernigan, D. B. (2018) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6703a1 · Cited by 1,632
Vaccines for preventing influenza in healthy adults
Jefferson, T., Di Pietrantonj, C., Rivetti, A., Bawazeer, G. A., Al-Ansary, L. A., & Ferroni, E. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001269.pub4 · Cited by 896
Influenza vaccine: The challenge of antigenic drift
CARRAT, F., & FLAHAULT, A. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.07.027 · Cited by 708
Effectiveness of Influenza Vaccine in the Community-Dwelling Elderly
Nichol, K. L., Nordin, J. D., Nelson, D. B., Mullooly, J. P., & Hak, E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070844 · Cited by 656
Metadata
- Authors
- Ohmit, S. E., Victor, J. C., Rotthoff, J. R., Teich, E. R., Truscon, R. K., Baum, L. L., Rangarajan, B., Newton, D. W., Boulton, M. L., & Monto, A. S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-12-14
- Volume
- 355
- Issue
- 24
- Pages
- 2513-2522
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2111693224
- Cited by
- 295
- References
- 16
- FWCI
- 18.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.